17-47361412-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152347.5(EFCAB13):c.696A>G(p.Ile232Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000787 in 1,613,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152347.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFCAB13 | ENST00000331493.7 | c.696A>G | p.Ile232Met | missense_variant | Exon 10 of 25 | 1 | NM_152347.5 | ENSP00000332111.2 | ||
EFCAB13 | ENST00000517484.5 | c.518-9025A>G | intron_variant | Intron 8 of 21 | 2 | ENSP00000430048.1 | ||||
EFCAB13 | ENST00000517310.5 | c.74-9025A>G | intron_variant | Intron 9 of 10 | 2 | ENSP00000466136.1 | ||||
EFCAB13 | ENST00000520776.5 | n.686A>G | non_coding_transcript_exon_variant | Exon 7 of 14 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152166Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000155 AC: 39AN: 251346Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135844
GnomAD4 exome AF: 0.0000794 AC: 116AN: 1461422Hom.: 0 Cov.: 31 AF XY: 0.0000853 AC XY: 62AN XY: 727008
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152284Hom.: 0 Cov.: 31 AF XY: 0.0000537 AC XY: 4AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.696A>G (p.I232M) alteration is located in exon 10 (coding exon 7) of the EFCAB13 gene. This alteration results from a A to G substitution at nucleotide position 696, causing the isoleucine (I) at amino acid position 232 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at